Tenon Medical Announces $3.0M Private Placement with Warrants

What Happened

• Tenon Medical, Inc. announced a private placement under a Securities Purchase Agreement entered Aug 27, 2026 and closed Aug 31, 2026 with an institutional investor. The company sold pre-funded warrants to purchase up to 597,610 shares of common stock (pre-funded warrant purchase price $5.019 each) and issued Series A warrants to purchase up to 1,058,517 shares. The Company received gross proceeds of $2,999,404.59 (plus a potential $597.61 upon exercise of the pre-funded warrants). WallachBeth Capital LLC served as placement agent.

Key Details

• Gross proceeds received: $2,999,404.59 (private placement closed Aug 31, 2026).
• Pre-Funded Warrants: up to 597,610 shares; purchase price $5.019 per pre-funded warrant; nominal exercise price $0.001 per share to convert; exercise cap prevents ownership >9.99% after exercise. Expected $597.61 payable on full exercise.
• Series A Warrants: up to 1,058,517 shares; exercise price $5.02 per share; immediately exercisable; expire 5 years from issuance; default ownership blocker at 4.99% (can be adjusted up to 9.99% with 61 days’ notice).
• Placement agent fee: 7% of gross proceeds plus reimbursement of certain expenses and legal fees.
• Registration rights: company must file a resale registration statement within 15 days and use best efforts to have it effective within 45 days (75 days if SEC conducts a full review).
• Use of proceeds: repayment of certain debt, working capital and general corporate purposes.

Why It Matters

• The financing provides nearly $3.0M in immediate cash to reduce debt and support operations, but it also creates potential future dilution if the warrants are exercised (up to ~1.66M shares in aggregate if all warrants convert). The registration commitment means warrant holders should be able to resell shares once the registration statement is effective. Placement fees and expense reimbursements reduce net proceeds. Investors should watch subsequent registration filings, any exercises of warrants, and resulting changes to the company’s share count.